Clinical trial
Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in…
NCT00274755 · University of California, San Francisco, Other · Completed
Key facts
| NCT number | NCT00274755 |
|---|---|
| Title | Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Evaluating Patients Who Are Undergoing Treatment for Gliomas |
| Official title | Improved Characterization of Brain Tumors By MRI and MRS |
| Lead sponsor | University of California, San Francisco, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | chemotherapy, conventional surgery, magnetic resonance imaging, magnetic resonance spectroscopic imaging, radiation therapy |
| Enrollment | 250 |
| Start date | Nov 1, 2003 |
| Primary completion | Apr 1, 2007 |
| First posted | Jan 11, 2006 |
| Last update posted | May 20, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: